SARS‐COV‐2 (COVID‐19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments
H Parlakpinar, M Gunata - Cell Biochemistry and Function, 2021 - Wiley Online Library
COVID‐19 caused by SARS‐COV‐2 first appeared in the Wuhan City of China and began to
spread rapidly among people. Rapid progression of the outbreak has led to a major global …
spread rapidly among people. Rapid progression of the outbreak has led to a major global …
[HTML][HTML] COVID-19: systemic pathology and its implications for therapy
Q Shen, J Li, Z Zhang, S Guo, Q Wang… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Responding to the coronavirus disease 2019 (COVID-19) pandemic has been an
unexpected and unprecedented global challenge for humanity in this century. During this …
unexpected and unprecedented global challenge for humanity in this century. During this …
Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics
Abstract The coronavirus disease (COVID-19) arises from the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) which is an enveloped RNA virus. COVID-19 has …
syndrome coronavirus-2 (SARS-CoV-2) which is an enveloped RNA virus. COVID-19 has …
[HTML][HTML] A review on Coronavirus Disease and potentially active drugs targeting Coronavirus
T Verma, M Sinha, B Nitin, SR Yadav… - Biomedical and …, 2021 - journals.lww.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus with single
positive-strand RNA, having glycoproteins projection on envelopes so reveals a halo-like …
positive-strand RNA, having glycoproteins projection on envelopes so reveals a halo-like …
COVID-19—Toward a comprehensive understanding of the disease
MM Kowalik, P Trzonkowski… - Cardiology …, 2020 - journals.viamedica.pl
The evidence on the pathophysiology of the novel coronavirus SARS-CoV-2 infection is
rapidly growing. Understanding why some patients suffering from COVID-19 are getting so …
rapidly growing. Understanding why some patients suffering from COVID-19 are getting so …
[HTML][HTML] Recent advances in pathophysiology, drug development and future perspectives of SARS-CoV-2
The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly pathogenic
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting …
Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
H Li, Z Liu, J Ge - Journal of cellular and molecular medicine, 2020 - Wiley Online Library
A cluster of pneumonia (COVID‐19) cases have been found in Wuhan China in late
December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was …
December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was …
[HTML][HTML] Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection
Objectives There are several types of research on the COVID-19 disease which have been
conducting. It seems that prevailing over the pandemic would be achieved only by mastering …
conducting. It seems that prevailing over the pandemic would be achieved only by mastering …
[PDF][PDF] COVID-19: A pandemic declare by world health organization
ABSTRACT A novel coronavirus (SARS-CoV-2, currently known as 2019-nCoV) cause an
acute respiratory disease which is termed as the coronavirus disease 2019 (COVID-19) …
acute respiratory disease which is termed as the coronavirus disease 2019 (COVID-19) …
[HTML][HTML] The pathophysiology, diagnosis and treatment of corona virus disease 2019 (COVID-19)
SK Das - Indian Journal of Clinical Biochemistry, 2020 - Springer
Since the beginning of this century, beta coronaviruses (CoV) have caused three zoonotic
outbreaks. However, little is currently known about the biology of the newly emerged SARS …
outbreaks. However, little is currently known about the biology of the newly emerged SARS …